119 related articles for article (PubMed ID: 6469767)
1. Identification of bromodeoxyuridine in malignant and normal cells following therapy: relationship to complications.
Morstyn G; Kinsella T; Hsu SM; Russo A; Gratzner H; Mitchell J
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1441-5. PubMed ID: 6469767
[TBL] [Abstract][Full Text] [Related]
2. Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
Kinsella TJ; Mitchell JB; Russo A; Aiken M; Morstyn G; Hsu SM; Rowland J; Glatstein E
J Clin Oncol; 1984 Oct; 2(10):1144-50. PubMed ID: 6092551
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
Hegarty TJ; Thornton AF; Diaz RF; Chandler WF; Ensminger WD; Junck L; Page MA; Gebarski SS; Hood TW; Stetson PL
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):421-8. PubMed ID: 2168357
[TBL] [Abstract][Full Text] [Related]
4. Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR.
Mitchell JB; Morstyn G; Russo A; Kinsella TJ; Fornace A; McPherson S; Glatstein E
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1447-51. PubMed ID: 6469768
[TBL] [Abstract][Full Text] [Related]
5. A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
Kinsella TJ; Russo A; Mitchell JB; Rowland J; Jenkins J; Schwade J; Myers CE; Collins JM; Speyer J; Kornblith P
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):69-76. PubMed ID: 6321412
[TBL] [Abstract][Full Text] [Related]
6. Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Eisbruch A; Robertson JM; Johnston CM; Tworek J; Reynolds KR; Roberts JA; Lawrence TS
J Clin Oncol; 1999 Jan; 17(1):31-40. PubMed ID: 10458215
[TBL] [Abstract][Full Text] [Related]
7. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
Morstyn G; Hsu SM; Kinsella T; Gratzner H; Russo A; Mitchell JB
J Clin Invest; 1983 Nov; 72(5):1844-50. PubMed ID: 6355188
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors.
Matsutani M; Kohno T; Nagashima T; Nagayama I; Matsuda T; Hoshino T; Sano K
Radiat Med; 1988; 6(1):33-9. PubMed ID: 3045898
[TBL] [Abstract][Full Text] [Related]
9. Mucocutaneous complications of intraarterial 5-bromodeoxyuridine and radiation.
McCuaig CC; Ellis CN; Greenberg HS; Hegarty TJ; Page MA
J Am Acad Dermatol; 1989 Dec; 21(6):1235-40. PubMed ID: 2584461
[TBL] [Abstract][Full Text] [Related]
10. In vivo incorporation of bromodeoxyuridine into proliferating cells in the marrow and its effects on granulocyte-macrophage progenitor cells.
Morstyn G; Kinsella T; Shan CS; Whang-Peng J; Russo A; Mitchell JB
Exp Hematol; 1985 May; 13(4):289-94. PubMed ID: 3987831
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR).
Mitchell JB; Kinsella TJ; Russo A; McPherson S; Rowland J; Smith BH; Kornblith PL; Glatstein E
Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):457-63. PubMed ID: 6303991
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial 5-bromo-2-deoxyuridine (BUdR) radiosensitization with external beam radiation in rhesus monkeys: toxicity study.
Greenberg HS; Chandler WF; Diaz RF; Averill DR; Gebarski SS; Lichter AS; Ensminger WD
J Neurooncol; 1988 Dec; 6(4):349-54. PubMed ID: 3221261
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
Greenberg HS; Chandler WF; Diaz RF; Ensminger WD; Junck L; Page MA; Gebarski SS; McKeever P; Hood TW; Stetson PL
J Neurosurg; 1988 Oct; 69(4):500-5. PubMed ID: 3047341
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of radiation-induced mitotic inhibition by BUdR incorporation in L-cells.
Schneider DO; Johns RM
Radiat Res; 1966 Jul; 28(3):657-67. PubMed ID: 5938770
[No Abstract] [Full Text] [Related]
15. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
Greenberg HS; Chandler WF; Ensminger WD; Sandler H; Junck L; Page MA; Crane D; McKeever P; Tankanow R; Bromberg J
Neurology; 1994 Sep; 44(9):1715-20. PubMed ID: 7936303
[TBL] [Abstract][Full Text] [Related]
16. 5-bromodeoxyuridine (BUdR) quenching of acridine orange fluorescence distinguishes cycling and non-cycling normal and malignant bone marrow cells in vitro.
Maddox AM; Johnson DA; Keating MJ
Leuk Res; 1989; 13(9):781-90. PubMed ID: 2796384
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
Danova M; Riccardi A; Gaetani P; Wilson GD; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
[TBL] [Abstract][Full Text] [Related]
18. In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections.
Danova M; Riccardi A; Brugnatelli S; Fiocca R; Girino M; Villani L; Giordano P; Dionigi P; Giordano M; Buttini R
Histochem J; 1988 Mar; 20(3):125-30. PubMed ID: 2842278
[TBL] [Abstract][Full Text] [Related]
19. Cell kinetics evaluation of colorectal tumors after in vivo administration of bromodeoxyuridine.
Roncucci L; Pedroni M; Scalmati A; Bormioli ML; Sassatelli R; Fante R; Losi L; Di Gregorio C; Petocchi B; Ponz de Leon M
Int J Cancer; 1992 Dec; 52(6):856-61. PubMed ID: 1459724
[TBL] [Abstract][Full Text] [Related]
20. The effects of "BAR" therapy on oral malignant tumors.
Nagai T; Sakaizumi K; Asanami S; Lian SL; Tomita O; Hirayama T
J Maxillofac Surg; 1978 May; 6(2):98-103. PubMed ID: 353211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
